Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
9p21 deletion correlates with recurrence in head and neck cancer
William M. Lydiatt
, Bruce J. Davidson
, Stimson P. Schantz
, Salvatore Caruana
, Raju S.K. Chaganti
Research output
:
Contribution to journal
›
Article
›
peer-review
56
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of '9p21 deletion correlates with recurrence in head and neck cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Head-and-neck Cancer
100%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
9p21 Deletion
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
80%
Loss of Heterozygosity
60%
Interferon-α (IFN-α)
40%
Tumor Suppressor Gene
40%
9p21
40%
Neoplasms
20%
Oncogenesis
20%
Stimulator of Interferon Genes (STING)
20%
Human Tumors
20%
Survival Analysis
20%
Gene Cluster
20%
PCR-based
20%
Distant Recurrence
20%
Aggressive Disease
20%
Prognostic Tool
20%
Locoregional Recurrence
20%
Polymorphic Markers
20%
Deletion Mapping
20%
Cyclin-dependent Kinase 4 Inhibitor
20%
Biochemistry, Genetics and Molecular Biology
Loss of Heterozygosity
100%
Interferon
100%
Tumor Suppressor Gene
66%
Carcinogenesis
33%
Gene Cluster
33%
Cyclin-Dependent Kinase 4
33%
P16
33%
Gene Mapping
33%